Tablo Demonstrates High Treatment Completion Among Users

A perennial concern of nephrologists who are not familiar with home HD is that patients at home won’t do their treatments. Results of a new trial with the Outset Tablo should ease their minds. The study found that treatment adherence was 95%, with 92% of treatments completing at least 90% of the prescribed time.

Read the full article » | Posted 11-16-2022

Related Articles